Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,165,808
-
Total 13F shares
-
82,444,744
-
Share change
-
+5,033,202
-
Total reported value
-
$1,069,165,081
-
Put/Call ratio
-
42%
-
Price per share
-
$12.96
-
Number of holders
-
135
-
Value change
-
+$62,280,208
-
Number of buys
-
76
-
Number of sells
-
49
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2020
As of 30 Sep 2020,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,444,744 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, Redmile Group, LLC, MAVERICK CAPITAL LTD, BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, Consonance Capital Management LP, STATE STREET CORP, GOLDMAN SACHS GROUP INC, and WASATCH ADVISORS INC.
This page lists
135
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.